45 hasil untuk "David Capper"
Menampilkan 1–20 · 0,54 detik · RSS
-
Artikel Jurnal
[68Ga]Ga-PSMA PET/MRI, histological PSMA expression and preliminary experience with [177Lu]Lu-PSMA therapy in relapsing high-grade glioma
PurposeHigh-grade gliomas (HGG) are still associated with a dismal prognosis. Prostate specific membrane antigen (PSMA) is discussed as a theranostic target for PSMA-directed radioligand therapy ([177Lu]Lu-PSMA RLT). Here, we report on the correlation of [68Ga]Ga-PSMA uptake with histological PSMA…
-
Artikel Jurnal
The interdisciplinary management of craniopharyngioma – practice patterns, outcomes, and insights
Abstract Background Craniopharyngiomas are rare, mostly benign brain tumors, and their management remains challenging due to the limited data from large cohorts. This study evaluates the practice patterns and outcomes for craniopharyngioma patients managed at a tertiary care center. Methods This…
-
Artikel Jurnal
Real-world experience with TTFields in glioma patients with emphasis on therapy usage
Tumor Treating Fields (TTFields) has emerged as a significant adjunctive component in the treatment of high-grade gliomas following the EF-14 trial in 2017. The incorporation of TTFields, alongside cyclic temozolomide therapy, has demonstrated improved patient outcomes when the usage exceeds 18 h…
-
Artikel Jurnal
DNA methylation-based profiling is an effective asset for identification of tumors in suspected, yet immunohistochemically, unspecified neuro-oncological cases
Introduction: Patients with suspected neuro-oncological disease on radiographic images and no histopathological evidence of a tumor on the surgically retrieved tissue, pose a great challenge for clinicians and neuropathologists. Meanwhile, genome-wide DNA methylation-based molecular profiling has…
-
Artikel Jurnal
Explainable artificial intelligence of DNA methylation-based brain tumor diagnostics
Abstract We have recently developed a machine learning classifier that enables fast, accurate, and affordable classification of brain tumors based on genome-wide DNA methylation profiles that is widely employed in the clinic. Neuro-oncology research would benefit greatly from understanding the…
-
Artikel Jurnal Teks lengkap
cIMPACT‐NOW update 7: advancing the molecular classification of ependymal tumors
Advances in our understanding of the biological basis and molecular characteristics of ependymal tumors since the latest iteration of the World Health Organization (WHO) classification of CNS tumors (2016) have prompted the cIMPACT-NOW group to recommend a new classification. Separation of…
-
Artikel Jurnal
Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre
Abstract The introduction of the classification of brain tumours based on their DNA methylation profile has significantly changed the diagnostic approach for cases with ambiguous histology, non-informative or contradictory molecular profiles or for entities where methylation profiling provides…
-
Artikel Jurnal
Concurrent IDH1 and SMARCB1 Mutations in Pediatric Medulloblastoma: A Case Report
Isocitrate Dehydrogenase-1 (IDH1) is a driver gene in several cancers including brain tumors such as low-grade and high-grade gliomas. Mutations of SMARCB1 were described in atypical teratoid rhabdoid tumors and to date have not been associated with the pathogenesis of medulloblastoma. We report…
-
Artikel Jurnal
Malignant transformation and genetic alterations are uncoupled in early colorectal cancer progression
Abstract Background Colorectal cancer (CRC) development is generally accepted as a sequential process, with genetic mutations determining phenotypic tumor progression. However, matching genetic profiles with histological transition requires the analyses of temporal samples from the same patient at…
-
Artikel Jurnal
Re-resection of brain metastases – outcomes of an institutional cohort study and literature review
Abstract Background Surgically accessible brain metastases are treated through microsurgical removal followed by radiation therapy, resulting in improved progression-free and overall survival. Some patients experience recurrence, prompting the need for effective management strategies. Despite the…
-
Artikel Jurnal
Time-dependent prognostic value of automated Ki67 assessment and its integration with molecular risk profiling in WHO grade 2 meningioma
Abstract WHO grade 2 meningiomas exhibit highly heterogeneous clinical courses. While the Ki67 proliferation index is a standard biomarker, its prognostic utility remains limited by methodological inconsistency and potential time-dependent dynamics. We evaluated an automated, artifact-adjusted Ki67…
-
Artikel Jurnal
Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomas
Abstract The combination of DNA methylation analysis with histopathological and genetic features allows for a more accurate risk stratification and classification of meningiomas. Nevertheless, the implications of this classification for patients with grade 2 meningiomas, a particularly…
-
Artikel Jurnal Teks lengkap
Survival According to BRAF-V600 Tumor Mutations – An Analysis of 437 Patients with Primary Melanoma
The prognostic impact of BRAF-V600 tumor mutations in stage I/II melanoma patients has not yet been analyzed in detail. We investigated primary tumors of 437 patients diagnosed between 1989 and 2006 by Sanger sequencing. Mutations were detected in 38.7% of patients and were associated with age…
-
Artikel Jurnal
Heterogeneity of DNA methylation profiles and copy number alterations in 10782 adult-type glioblastomas, IDH-wildtype
The morphological patterns leading to the diagnosis of glioblastoma may also commonly be observed in several other distinct tumor entities, which can result in a mixed bag of tumors subsumed under this diagnosis. The 2021 WHO Classification of CNS Tumors has separated several of these entities from…
-
Artikel Jurnal
Single nucleus RNA profiling reveals potential therapeutic vulnerabilities in sinonasal carcinomas
Abstract Sinonasal undifferentiated carcinomas are rare, aggressive tumors with limited treatment options. Molecular subgroups defined by IDH2 mutations or SWI/SNF complex deficiencies have recently been recognized, but therapeutic implications remain unclear. We performed single-nucleus RNA…
-
Artikel Jurnal
Reference on copy number variations in pleomorphic xanthoastrocytoma: Implications for diagnostic approach
Pleomorphic xanthoastrocytoma (PXA) poses a diagnostic challenge. The present study relies on methylation-based predictions and focuses on copy number variations (CNV) in PXA. We identified 551 tumors from patients having received the histologic diagnosis or differential diagnosis pleomorphic…